Repros Therapeutics (RPRX) Reports Q2 Loss of $0.18/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.30 +0.87%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
CRMT, PKE, HELE, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
CRMT, PKE, HELE, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q2 EPS of ($0.18), versus ($0.32) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
- Keurig Dr Pepper (KDP) PT Raised to $39 at Bernstein SocGen Group
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
